Cargando…
Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors
Histone lysine specific demethylase 1 (LSD1) has become a potential therapeutic target for the treatment of cancer. Discovery and develop novel and potent LSD1 inhibitors is a challenge, although several of them have already entered into clinical trials. Herein, for the first time, we reported the d...
Autores principales: | Ma, Liying, Wang, Haojie, You, Yinghua, Ma, Chaoya, Liu, Yuejiao, Yang, Feifei, Zheng, Yichao, Liu, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563019/ https://www.ncbi.nlm.nih.gov/pubmed/33088686 http://dx.doi.org/10.1016/j.apsb.2020.02.006 |
Ejemplares similares
-
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
por: Li, Zhonghua, et al.
Publicado: (2019) -
Synthesis and Antifungal Activity of Benzamidine Derivatives Carrying 1,2,3-Triazole Moieties
por: Chen, Guangyou, et al.
Publicado: (2014) -
Synthesis and Antiproliferative Evaluation of Novel Hybrids of Dehydroabietic Acid Bearing 1,2,3-Triazole Moiety
por: Li, Fang-Yao, et al.
Publicado: (2019) -
1,2,3-Triazoles
por: Rachwal, S., et al.
Publicado: (2008) -
Antibacterial Activities and Molecular Docking of Novel Sulfone Biscompound Containing Bioactive 1,2,3-Triazole Moiety
por: Rashdan, Huda R. M., et al.
Publicado: (2021)